Edition:
United States

Pharmagest Interactive SA (PHAI.PA)

PHAI.PA on Paris Stock Exchange

51.50EUR
4:16am EDT
Change (% chg)

€-0.01 (-0.02%)
Prev Close
€51.51
Open
€51.61
Day's High
€52.55
Day's Low
€51.00
Volume
3,812
Avg. Vol
2,655
52-wk High
€52.55
52-wk Low
€28.66

Latest Key Developments (Source: Significant Developments)

Pharmagest Interactive FY revenue up at 128.4 million euros
Wednesday, 15 Feb 2017 12:00pm EST 

Pharmagest Interactive Sa :FY revenue 128.4 million euros ($136.1 million) versus 113.5 million euros year ago.  Full Article

Pharmagest Interactive acquires 80 pct stake in Noviatek
Monday, 22 Aug 2016 01:02pm EDT 

Pharmagest Interactive SA : Acquires an 80 pct stake in company Noviatek, which becomes a subsidiary of Pharmagest Group Further company coverage: [PHAI.PA] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;)).  Full Article

Pharmagest Interactive Q2 revenue up 13.45% at 33.1 million euros
Wednesday, 10 Aug 2016 12:30pm EDT 

Pharmagest Interactive SA :Q2 revenue 33.1 million euros ($36.98 million) versus 29.2 million euros year ago.  Full Article

Pharmagest Interactive Q1 revenue up 12.7% at 30.5 million euros
Thursday, 12 May 2016 12:01pm EDT 

Pharmagest Interactive SA :Q1 revenue 30.5 million euros ($34.72 million) versus 27.0 million euros year ago.  Full Article

Pharmagest Interactive to propose a gross dividend of 0.60 euros per share
Friday, 1 Apr 2016 01:00pm EDT 

Pharmagest Interactive SA:Will propose a gross dividend of 0.60 euros per share.  Full Article

Pharmagest Interactive subsidiary announces acquisition of DICSIT
Wednesday, 23 Mar 2016 02:00pm EDT 

Pharmagest Interactive SA:Malta Informatique, a Pharmagest Group subsidiary, announces acquisition of DICSIT, a specialist in information systems for HADs (hospitals at home).  Full Article

Pharmagest Interactive announces partnership with TELUS Health
Friday, 18 Mar 2016 03:00pm EDT 

Pharmagest Interactive SA:Announces a strategic partnership between TELUS Health and DOmedic Inc., a Pharmagest subsidiary.Following TELUS Health's investment, the Pharmagest Group retains 26 pct of the capital.  Full Article

BRIEF-Pharmagest Interactive H1 net profit up 5.73 percent

* H1 NET INCOME GROUP SHARE EUR 10.6‍​ MILLION VERSUS EUR 10.0 MILLION YEAR AGO